Sex specific efficacy and safety outcomes in operable stage III non-small cell lung cancer (NSCLC): Pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14

被引：0
|
作者：
Frehner, L. [1 ]
Schaer, S. [2 ]
Hayoz, S. [2 ]
Guckenberger, M. [3 ]
Finazzi, T. [4 ]
Mark, M. T. [5 ]
Addeo, A. [6 ]
Mauti, L. A. [7 ]
Betticher, D. C. [8 ]
Stupp, R. [9 ]
Curioni-Fontecedro, A. [10 ]
Peters, S. [11 ]
Frueh, M. [12 ]
Rothschild, S. I. [13 ,14 ]
Pless, M.
Koenig, D. [15 ]
Schmitt-Opitz, I. [16 ]
Ris, H-B. [17 ]
Ozdemir, B. C. [1 ]
Schmid, S. [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland
[2] Swiss Grp Clin Canc Res SAKK Competence Ctr, Stat, Bern, Switzerland
[3] Univ Zurich, Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[4] Univ Hosp Basel, Clin Radiotherapy & Radiat Oncol, Basel, Switzerland
[5] Cantonal Hosp Graubuenden, Div Hematol Oncol, Chur, Switzerland
[6] Univ Hosp Geneva, Dept Oncol, Geneva, Switzerland
[7] Kantonsspital Winterthur, Dept Med Oncol, Winterthur, Switzerland
[8] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villars Sur Glane, Switzerland
[9] Northwestern Univ, Feinberg Sch Med, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[10] Univ Fribourg, Cantonal Hosp Fribourg, Clin Oncol, Villar Sur Glane, Switzerland
[11] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland
[12] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[13] Cantonal Hosp Baden, Ctr Oncol Hematol, Baden, Switzerland
[14] Cantonal Hosp Baden, Ctr Comprehens Canc, Baden, Switzerland
[15] Univ Hosp Basel, Dept Med Oncol, Basel, Switzerland
[16] Univ Zurich, Univ Zurich Hosp, Dept Thorac Surg, Zurich, Switzerland
[17] Hop Valais, Clin Thorac Surg, Sion, Switzerland
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1223P
引用
收藏
页码：S786 / S786
页数：1
相关论文
共 50 条
  • [11] SAKK 16/14-Perioperative Anti-PD-L1 Antibody Durvalumab in Patients with Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC)
    Rothschild, S.
    Zippelius, A.
    Savic, S.
    Gonzalez, M.
    Weder, W.
    Xyrafas, A.
    Rusterholz, C.
    Pless, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2149 - S2149
  • [12] AFT-16: Phase II trial of neoadjuvant and adjuvant atezolizumab and chemoradiation (CRT) for stage III non-small cell lung cancer (NSCLC).
    Ross, Helen J.
    Kozono, David E.
    Urbanic, James John
    Williams, Terence Marques
    DuFrane, Carter
    Bara, Ilze
    Schulze, Katja
    Brockman, Jane Michelle
    Wang, Xiaofei F.
    Gao, Junheng
    Vokes, Everett E.
    Stinchcombe, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [13] Detection of p16 abnormalities in early-stage non-small, cell lung cancer
    Niklinska, W
    Chyczewski, L
    Laudanski, J
    Chyczewska, E
    Niklinski, J
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 : 30 - 32
  • [14] Navelbine (NVB), oral etoposide (VP16), in advanced non-small cell lung cancer (NSCLC)
    Lopez, JO
    Federico, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1088 - 1088
  • [15] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials (vol 16, pg 634, 2015)
    Chang, J. J.
    Senan, S.
    Paul, M. M.
    LANCET ONCOLOGY, 2015, 16 (09): : E427 - E427
  • [16] The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution
    Martin, LW
    Correa, AM
    Hofstetter, W
    Hong, WK
    Komaki, R
    Putnam, JB
    Rice, DC
    Smythe, WR
    Swisher, SG
    Vaporciyan, AA
    Walsh, GL
    Roth, JA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (06): : 1601 - 1610
  • [17] The validation of a 16-gene expression signature in non-small cell lung cancer
    Wu, Yong
    Nan, Lily
    Chen, Hsuan-Yu
    Sciabica, Kathryn
    Yowanto, Handy
    Yu, Sung-Liang
    CANCER RESEARCH, 2009, 69
  • [18] P16 methylation and protein expression in non-small cell lung cancer
    Aviel-Ronen, Sarit
    Ling, Chunhua
    Lu, Ming
    Lau, Davina
    Ho, James
    Liu, Ni
    Tsao, Mingsound
    MODERN PATHOLOGY, 2006, 19 : 163 - 163
  • [19] Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer
    Ng, CSH
    Zhang, J
    Wan, S
    Lee, TW
    Arifi, AA
    Mok, T
    Lo, DYM
    Yim, APC
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (02) : 101 - 106
  • [20] p16 expression and survival in non-small cell lung cancer: Analysis of 414 cases
    Coffey, DM
    Castro, CY
    Gondo, MM
    Stephenson, MA
    Brown, RW
    Lebovitz, RM
    Cagle, PT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 949 - 949
12345